1. Short title This Act may be cited as the Opioids and STOP Pain Initiative Act . 2. Establishment There is established an Opioids and STOP Pain Initiative, to be administered by the Director of the National Institutes of Health, in coordination with other agencies, as appropriate, which shall include efforts to support research on the following: (1) Section 108 of the Comprehensive Addiction and Recovery Act of 2016 ( 42 U.S.C. 284q–1 ), known as the STOP Pain Act, which directs the National Institutes of Health to intensify and coordinate fundamental, translational, and clinical research with respect to— (A) the understanding of pain; (B) the discovery and development of therapies for chronic pain; and (C) the development of alternatives to opioids for effective pain treatments. (2) Developing improved options and evidence for medication-assisted treatment. (3) Developing improved options and evidence for opioid overdose reversal treatments. (4) The Federal Pain Research Strategy, including research that focuses on— (A) novel drugs, non-addictive, and non-pharmacological treatments for pain; (B) screening tools and outcome measure for assessments across the continuum of pain; (C) national registries, datasets, and research networks; (D) effective models of care delivery for pain management